BMSN, CERP, COIN & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

BMSN is a really good example of why we suggest that our readers keep a working watchlist of all of the stocks we mention, as there are instances when one of our more dated interests crops up with a new development that sends the stock on a ride. Such was the case with BMSN yesterday, as the company released a PR iterating the initiation of clinical trials for the company’s anemia treatment, HemaXellerate. As a result, yesterday’s trading carried the stock as high as .0062.

A week ago today, we mentioned that we’d like to see support hold at .0035 and .0021 to remain bullish on BMSN, which it did, in fact, manage. From the low of .0032 since last Wednesday’s mention, we are up 94% – From the low following our first ever alert (.0003 on Dec. 26th), yesterday’s high represented an unbelievably impressive gain of 1967%

Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I(TM) Stem Cell Drug for Aplastic Anemia

Clinical Trial to Evaluate “First in Class” Approach to Bone Marrow Failure Diseases

SAN DIEGO, CA, Feb 05, 2013 (MARKETWIRE via COMTEX) — Regen BioPharma a wholly-owned subsidiary of Bio-Matrix Scientific Group Inc. (PINKSHEETS: BMSN), announced today filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company’s HemaXellerate I(TM) stem cell drug in patients with drug-refractory aplastic anemia.

Cereplast, Inc. CERP

We first mentioned CERP as a feature on January 24th, at which time we saw a low of .023. On the 25th, it spiked 59% to .0365. This past Friday the stock saw another low of .0182, before running yesterday to a new high at .043, for an added gain of 136%, and bringing our total cumulative gains to 195% in just under two weeks’ time.

With the amount of momentum and volume we’ve seen trade through CERP recently, we definitely want to keep this one high on our watchlists.

Cereplast Provides Shareholder Update on Italian Application Decree & Announces $300,000 in New Revenue

EL SEGUNDO, Calif., Feb 05, 2013 (GLOBE NEWSWIRE via COMTEX) — Cereplast, Inc. (OTCQB:CERP) (the “Company”), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, generated approximately $300,000 in new revenue during the last two weeks of January 2013. These orders received are in addition to the $500,000 of new revenue that was announced on January 23, 2013.


Converted Organics, Inc. COIN

 COIN appeared on our extended watchlist yesterday, and thus posted a sizable gain, running from .0019-0029, only to close the day at .0025. That gave us a quick chance at up to 53% in intraday gains.

As most of you are undoubtedly aware, we first began really zeroing in on cannabis stocks back in October. From our continued reports on the subject this week, we have seen even more gains to add to the already monumental profits that these plays have afforded us. Our running tally of tracked pot stocks totaled 10 at the start of this week. We are all but certain that even more will crop up (no pun intended), as the fervor over this newly expanding market sector continues to intensify.

Extended Watchlist: